Stenabolic (SR-9009)

ACTIVE HALF-LIFE: 4 – 6 Hours
CLASSIFICATION: PPARS AGONIST
DOSAGE: 15mg/Pill
ACNE: NO
WATER RETENTION: NO
HBR: NO
HEPATOXITY: NO
AROMATIZATION: NO

Stenabolic (SR 9009) is a developing PPAR alpha modulator, created by Professor Thomas Burris at the Scripps Research Institute in 2015. It is promoted as a SARM and research chemical, often likened to Cardarine (GW-501516) because of its agonistic effects on Rev-ErbA. An article in "National Medicine" indicates that SR 9009 boosts exercise performance in mice by increasing mitochondrial density in skeletal muscle, leading to its online nickname "exercise in a bottle."

As noted earlier, Stenabolic can impact mitochondrial function within skeletal muscle, which effectively enhances metabolic activity. This quality makes it comparable to DNP; however, SR 9009 is significantly safer and supports endurance rather than hindering it. Unlike DNP, SR 9009 can provide the benefits of aerobic exercise without the requirement of physical training, thereby improving endurance instead of diminishing it.

SR 9009 interacts with a protein called Rev-erbA, which plays a vital role in the metabolism of fats and sugars in the liver, fat cell generation, and inflammatory processes in the body. This interaction means that SR 9009 can boost the effectiveness of your current exercise routine, making even times of inactivity less harmful to your fitness goals. The main aim is to convert energy from consumed food into usable energy rather than storing it as fat, a process in which SR 9009 excels. Additionally, SR 9009 promotes the breakdown of existing fat stores.

Stenabolic (SR 9009) aids in achieving greater leanness and enables longer cardio sessions with less fatigue, ultimately improving VO2 max and overall endurance.

Moreover, SR 9009 may offer benefits for non-athletes by tackling issues like obesity, metabolic syndrome, and type 2 diabetes.

Research involving mice with low muscle mass, a sluggish metabolism, and limited endurance showed that SR 9009 markedly improved muscle growth and metabolic rates, even without physical activity. When these mice were given the chance to run, they increased their running distance by 50% without experiencing increased fatigue.

SR 9009 does not act like traditional fat burners, thyroid stimulants, or appetite suppressants (such as clenbuterol, T3, or similar stimulants). As a result, users are unlikely to face crashes or fatigue while using it. Nevertheless, as it is still relatively novel and has seen limited use among human athletes, further information on potential side effects is awaited.

Stenabolic is typically taken in doses of 20-30 milligrams (mg) per day, with the possibility of adjusting by 10 mg according to individual preference. The suggested cycle lasts from 6-8 weeks, and it is recommended to combine SR 9009 with Cardarine (GW-501516) for enhanced endurance benefits. Due to its shorter half-life, SR 9009 should be administered more frequently, ideally 3-4 times a day, though some users have successfully managed with 2-3 doses per day.